You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
In health tech news today, Oura reports a profit, the FDA loses another key digital health leader, and more ...
An experimental Novartis drug for a rare neuromuscular condition failed to improve muscle function in a pivotal study ...
Roivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more biotech news ...
An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market ...
A Novartis drug for a rare neuromuscular condition failed in a key study, the company's second major trial collapse in a ...
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for ...
Katherine Clark, a top House Democrat, received more than $100,000 in campaign donations from people linked to UnitedHealth ...
Rural health systems are seeking partnership to survive, fueling a debate over competition and the rising cost of medical ...
Roivant said Tuesday an experimental drug for a type of pulmonary hypertension achieved the goals of a mid-stage study — ...
As a medical student in a larger body, I have often been ostracized, othered, made to feel different, like I’ve invaded a ...
The decision to move ahead with new products in the absence of FDA authorization could spur other big manufacturers to do the ...